GT Biopharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.

About GTBP

GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells). 

CEO
Michael Breen
CEOMichael Breen
Employees
8
Employees8
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
1965
Founded1965
Employees
8
Employees8

GTBP Key Statistics

Market cap
58.45M
Market cap58.45M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
93.57K
Average volume93.57K
High today
$1.91
High today$1.91
Low today
$1.80
Low today$1.80
Open price
$1.82
Open price$1.82
Volume
71.78K
Volume71.78K
52 Week high
$7.48
52 Week high$7.48
52 Week low
$1.51
52 Week low$1.51

GTBP Earnings

-$1.83
-$1.22
-$0.61
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10
ActualExpected Nov 10
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.